Correlation Between Crescita Therapeutics and AusCann Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crescita Therapeutics and AusCann Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crescita Therapeutics and AusCann Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crescita Therapeutics and AusCann Group Holdings, you can compare the effects of market volatilities on Crescita Therapeutics and AusCann Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crescita Therapeutics with a short position of AusCann Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crescita Therapeutics and AusCann Group.

Diversification Opportunities for Crescita Therapeutics and AusCann Group

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between Crescita and AusCann is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Crescita Therapeutics and AusCann Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AusCann Group Holdings and Crescita Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crescita Therapeutics are associated (or correlated) with AusCann Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AusCann Group Holdings has no effect on the direction of Crescita Therapeutics i.e., Crescita Therapeutics and AusCann Group go up and down completely randomly.

Pair Corralation between Crescita Therapeutics and AusCann Group

If you would invest  0.38  in AusCann Group Holdings on August 25, 2024 and sell it today you would earn a total of  0.00  from holding AusCann Group Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

Crescita Therapeutics  vs.  AusCann Group Holdings

 Performance 
       Timeline  
Crescita Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Crescita Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Crescita Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
AusCann Group Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days AusCann Group Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly weak basic indicators, AusCann Group reported solid returns over the last few months and may actually be approaching a breakup point.

Crescita Therapeutics and AusCann Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crescita Therapeutics and AusCann Group

The main advantage of trading using opposite Crescita Therapeutics and AusCann Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crescita Therapeutics position performs unexpectedly, AusCann Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AusCann Group will offset losses from the drop in AusCann Group's long position.
The idea behind Crescita Therapeutics and AusCann Group Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets